24 February 2020 ORYZON Reports Financial Results and Corporate Update for the 4thQuarter and Year Ended December 31, 2019
9 December 2019 ORYZON presents new efficacy data from its Phase II trial ALICE investigating iadademstat in AML
3 October 2019 ORYZON Presents New Positive REIMAGINE Efficacy Data of Vafidemstat in the Treatment of Aggression